Treatment of skin conditions by dickkopf1 (dkk1)
AssigneeThe Govt. of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
InventorsVincent Hearing, Yuji Yamaguchi, Thierry Passeron
Life of this patent
Estimating the term…
Abstract
The present disclosure is generally related to methods of inducing non-palmoplantar skin to develop a palmoplantar phenotype, for example, methods for increasing skin thickness, decreasing skin pigmentation, and/or decreasing hair growth. In particular, disclosed herein are methods of using topical administration of DKK1 to increase skin thickness, decrease skin pigmentation, or reduce hair growth. Also disclosed are topical DKK1 compositions for inducing non-palmoplantar skin to develop a palmoplantar phenotype.
Claims20
A method for treating a dermatological pathology, comprising:
- topically applying an effective amount of DKK1 to non-palmoplantar skin, thereby inducing the non-palmoplantar skin to develop a palmoplantar phenotype and treating the dermatological pathology, wherein the dermatological pathology is a skin graft, an ulcer, an abrasion, an injury caused by a repetitive impact or mechanical stress, age-related skin changes, skin damage due to steroid treatment, uneven skin pigmentation, hyperpigmentation, post-inflammatory pigmentation, fragrance dermatitis, ephelides, vitiligo, a pigmented birthmark, lentigos, or skin changes due to lichen simplex chronicus, melasma, Addison's disease, Peutz-Jeghers syndrome, acanthosis nigricans, hirsutism, congenital adrenal hyperplasia, polycystic ovarian syndrome, hypertrichosis, porphyria cutanea tarda, anorexia nervosa, or melanoma.
Dependencies are inferred from the claim text.